🇺🇸 FDA
Patent

US 7763259

Therapeutic and prophylactic vaccine for the treatment and prevention of papillomavirus infection

granted A61KA61K2039/5256A61K2039/5258

Quick answer

US patent 7763259 (Therapeutic and prophylactic vaccine for the treatment and prevention of papillomavirus infection) held by The Regents of the University of Colorado expires Mon Jul 22 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of Colorado
Grant date
Tue Jul 27 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 22 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K2039/5256, A61K2039/5258, A61K2039/585, A61K39/12